Author/Editor     Koraka, P; Avšič-Županc, T; Osterhaus, ADME; Groen, J
Title     Evaluation of two commercially available immunoassays for the detection of hantavirus antibodies in serum samples
Type     članek
Source     J Clin Virol
Vol. and No.     Letnik 17, št. 3
Publication year     2000
Volume     str. 189-96
Language     eng
Abstract     Background: hantaviruses are members of the family Bunyaviridae and the spectrum of clinical symptoms in humans may vary from sub-clinical to severe haemorrhagic fever with with renal syndrome (HFRS) or pulmonary syndrome (HPS). Several serotypes have been described from which at least five are pathogenic to humans. Each serotype has a different animal reservoir and geographical distribution. In the acute phase of the disease the clinical diagnosis may be confirmed by serology or by polymerase-chain reaction (PCR). Objective: to evaluate two commercially available immunoassays using sera from hantavirus suspected and non-hantavirus patients: an enzyme immunoassay (EIA) developed by MRL diagnostics, for the detection of immunoglobulins M (IgM) and G (IgG) against several hantavirus serotypes and an indirect immunofluorescence assay (IFA) from Progen, based on slides coated with Hantaan virus (HNTV) and Puumala virus (PUUV), infected cells. Study design: a total of 145 serum samples were used for this study. The serum panel included serum samples from patients suspected of mild (n = 91), severe (n = 10) HFRS and patients with other viral infections (n = 44). Results: the agreement between the MRL EIA and the Progen IFA for the detection of IgM and IgG serum antibodies ranged from 87 to 91%, respectively. In the non-hantavirus group one out of 44 samples was positive by the Progen HNTV IgM IFA, none in the Progen PUUV IFA and two samples in the MRL IgM EIA, resulting in specifities of 98, 100 and 95%, respectively. (Abstract truncated at 2000 characters).
Descriptors     HANTAVIRUS
HANTAVIRUS INFECTIONS
IMMUNOENZYME TECHNIQUES
FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT
IGM
IGG
ANTIBODIES, VIRAL
SENSITIVITY AND SPECIFICITY